A variation of the Nijmegen-Bethesda assay using heat or a novel heat/cold pretreatment for the detection of FIX inhibitors in the presence of residual FIX activity
Summary Introduction The inclusion of a heat treatment step has improved the classic Nijmegen‐Bethesda assay for detection of factor VIII (FVIII) inhibitors in the presence of residual FVIII activity (FVIII:C). However, information regarding heat‐modified Nijmegen‐Bethesda assays for the detection o...
Saved in:
Published in: | International journal of laboratory hematology Vol. 38; no. 6; pp. 639 - 647 |
---|---|
Main Authors: | , , , |
Format: | Journal Article |
Language: | English |
Published: |
England
Blackwell Publishing Ltd
01-12-2016
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Summary
Introduction
The inclusion of a heat treatment step has improved the classic Nijmegen‐Bethesda assay for detection of factor VIII (FVIII) inhibitors in the presence of residual FVIII activity (FVIII:C). However, information regarding heat‐modified Nijmegen‐Bethesda assays for the detection of FIX inhibitors is still limited.
Methods
Three methods to measure FIX inhibitors in the presence or absence of residual FIX activity (FIX:C) using three different activated partial thromboplastin time (aPTT) reagents were investigated. These included the standard Nijmegen‐Bethesda assay (method 1), a heat‐modified assay (method 2) and a novel heat/cold‐modified assay (method 3).
Results
In the absence of FIX:C, all methods measured similar levels of FIX inhibitor, while FIX inhibitor titres varied widely in the presence of residual FIX:C. Using method 1, inhibitors were not accurately measured in the presence of residual circulating FIX:C. Using method 2, detection was improved, especially at higher inhibitor titres. Using method 3, some additional sensitivity was obtained. The choice of aPTT reagent did not affect the detection of inhibitors.
Conclusion
Heat pretreatment is recommended for detecting FIX inhibitors in samples with residual FIX:C. The heat/cold modification improved the sensitivity of the Nijmegen‐Bethesda assay, resulting in higher tolerance for residual FIX:C. |
---|---|
Bibliography: | istex:DAE29181A5B860191DC5013D9EFB444FD43953E5 Novo Nordisk A/S, Denmark ArticleID:IJLH12552 ark:/67375/WNG-TCT52NW7-9 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 1751-5521 1751-553X |
DOI: | 10.1111/ijlh.12552 |